During the past decade, Eyeclinic Albury Wodonga conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eyeclinic Albury Wodonga" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Ionis Pharmaceuticals, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Okogen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eyeclinic Albury Wodonga" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Eyeclinic Albury Wodonga" are "Geographic Atrophy" (4 trials), "Macular Edema" (2 trials), "Neovascular Age-Related Macular Degeneration" (2 trials), "Adenoviral Conjunctivitis" (1 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Eyeclinic Albury Wodonga" in a lesser frequency.

Most popular intervention types in "Eyeclinic Albury Wodonga" are "Drug" (12 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eyeclinic Albury Wodonga" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Eyeclinic Albury Wodonga". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Eyeclinic Albury Wodonga, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eyeclinic Albury Wodonga, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".